(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 4.89% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.3%.
Elanco Animal Health's revenue in 2026 is $5,020,000,000.On average, 17 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,615,520,280,050, with the lowest ELAN revenue forecast at $2,498,109,150,000, and the highest ELAN revenue forecast at $2,729,933,679,120. On average, 17 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,757,412,879,770, with the lowest ELAN revenue forecast at $2,602,030,490,640, and the highest ELAN revenue forecast at $2,936,777,116,740.
In 2028, ELAN is forecast to generate $2,892,810,395,700 in revenue, with the lowest revenue forecast at $2,705,452,209,450 and the highest revenue forecast at $3,114,642,488,220.